300138 晨光生物
已收盘 04-30 15:00:00
资讯
新帖
简况
股市必读：晨光生物（300138）4月29日董秘有最新回复
证券之星 · 04-30 06:00
股市必读：晨光生物（300138）4月29日董秘有最新回复
【机构调研记录】浙商基金调研晨光生物、佐力药业
中金财经 · 04-28 08:12
【机构调研记录】浙商基金调研晨光生物、佐力药业
晨光生物：4月25日接受机构调研，国泰海通、鹏扬基金等多家机构参与
证券之星 · 04-27
晨光生物：4月25日接受机构调研，国泰海通、鹏扬基金等多家机构参与
股市必读：晨光生物一季报 - 第一季度单季净利润同比下降11.65%
证券之星 · 04-27
股市必读：晨光生物一季报 - 第一季度单季净利润同比下降11.65%
晨光生物(300138)4月20日股东户数1.89万户，较上期减少2.88%
证券之星 · 04-25
晨光生物(300138)4月20日股东户数1.89万户，较上期减少2.88%
晨光生物(300138.SZ)发布一季度业绩，归母净利润9672.16万元，下降11.65%
智通财经 · 04-24
晨光生物(300138.SZ)发布一季度业绩，归母净利润9672.16万元，下降11.65%
4月23日晨光生物现1笔折价15.67%的大宗交易 合计成交396万元
证券之星 · 04-23
4月23日晨光生物现1笔折价15.67%的大宗交易 合计成交396万元
股市必读：晨光生物（300138）4月15日董秘有最新回复
证券之星 · 04-16
股市必读：晨光生物（300138）4月15日董秘有最新回复
晨光生物：2026年棉籽业务将继续严格执行对锁经营模式
证券之星 · 04-15
晨光生物：2026年棉籽业务将继续严格执行对锁经营模式
晨光生物：美国FDA推动食品行业从合成色素向天然色素转型
证券之星 · 04-15
晨光生物：美国FDA推动食品行业从合成色素向天然色素转型
晨光生物：公司管理层始终重视公司价值的提升
证券之星 · 04-15
晨光生物：公司管理层始终重视公司价值的提升
西南证券：给予晨光生物买入评级
证券之星 · 04-12
西南证券：给予晨光生物买入评级
晨光生物：2025年实现归属于上市公司股东的净利润3.69亿元，同比增长292.21%
证券之星 · 04-09
晨光生物：2025年实现归属于上市公司股东的净利润3.69亿元，同比增长292.21%
晨光生物（300138）披露向参股公司增资进展公告，4月7日股价上涨0.51%
证券之星 · 04-07
晨光生物（300138）披露向参股公司增资进展公告，4月7日股价上涨0.51%
中邮证券：给予晨光生物买入评级
证券之星 · 04-03
中邮证券：给予晨光生物买入评级
晨光生物：公司目前生产经营正常，产品出口业务有序开展
证券之星 · 04-01
晨光生物：公司目前生产经营正常，产品出口业务有序开展
晨光生物最新公告：2026年第一季度净利同比变动-17.79%-5.04%
证券之星 · 03-30
晨光生物最新公告：2026年第一季度净利同比变动-17.79%-5.04%
晨光生物（300138）披露为参股公司银行借款提供担保的进展公告，3月27日股价上涨1.63%
证券之星 · 03-27
晨光生物（300138）披露为参股公司银行借款提供担保的进展公告，3月27日股价上涨1.63%
股市必读：晨光生物（300138）3月19日董秘有最新回复
证券之星 · 03-20
股市必读：晨光生物（300138）3月19日董秘有最新回复
晨光生物：莱鲍迪甙M高效生物合成项目入选河北省生物合成专项
证券之星 · 03-19
晨光生物：莱鲍迪甙M高效生物合成项目入选河北省生物合成专项
加载更多
公司概况
公司名称：
晨光生物科技集团股份有限公司
所属行业：
农副食品加工业
上市日期：
2010-11-05
主营业务：
晨光生物科技集团股份有限公司的主营业务是天然植物提取。公司的主要产品是天然色素、天然香辛料提取物和精油、天然营养及药用提取物、天然甜味剂、保健食品、油脂和蛋白。公司先后荣获农业产业化国家重点龙头企业、国家高新技术企业、国家技术创新示范企业。
发行价格：
30.00
{"stockData":{"symbol":"300138","market":"SZ","secType":"STK","nameCN":"晨光生物","latestPrice":11.53,"timestamp":1777532610000,"preClose":11.69,"halted":0,"volume":5549637,"delay":0,"changeRate":-0.0137,"floatShares":398000000,"shares":483000000,"eps":0.7372,"marketStatus":"已收盘","change":-0.16,"latestTime":"04-30 15:00:00","open":11.67,"high":11.73,"low":11.49,"amount":64398500,"amplitude":0.0205,"askPrice":11.53,"askSize":78,"bidPrice":11.52,"bidSize":1384,"shortable":0,"etf":0,"ttmEps":0.7372,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778031000000},"marketStatusCode":5,"adr":0,"adjPreClose":11.69,"symbolType":"stock","openAndCloseTimeList":[[1777512600000,1777519800000],[1777525200000,1777532400000]],"highLimit":12.86,"lowLimit":10.52,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":483100093,"isCdr":false,"pbRate":1.63,"roa":"--","peRate":15.64026,"roe":"2.82%","epsLYR":0.7636,"committee":0.536613,"marketValue":5570000000,"turnoverRate":0.0139,"status":1,"floatMarketCap":4593000000},"requestUrl":"/m/hq/s/300138","defaultTab":"news","newsList":[{"id":"2631652760","title":"股市必读：晨光生物（300138）4月29日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2631652760","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631652760?lang=zh_cn&edition=full","pubTime":"2026-04-30 06:00","pubTimestamp":1777500050,"startTime":"0","endTime":"0","summary":"截至2026年4月29日收盘，晨光生物报收于11.69元，上涨2.81%，换手率1.5%，成交量5.99万手，成交额6972.02万元。董秘最新回复投资者： 我司2025年辣椒红销量达到12000吨，创历史新高，同时保持了较高的增速。目前辣椒红市场相对平稳，产品价格环比稳中有增，后续随着市场存货消化及公司定制化产品占比的提升，产品毛利、销量将逐渐恢复。当日关注点来自交易信息汇总：4月29日主力资金净流入321.81万元，显示主力对个股短期态度偏积极。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000018088.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","300138"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630312341","title":"【机构调研记录】浙商基金调研晨光生物、佐力药业","url":"https://stock-news.laohu8.com/highlight/detail?id=2630312341","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630312341?lang=zh_cn&edition=full","pubTime":"2026-04-28 08:12","pubTimestamp":1777335145,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及4月27日披露的机构调研信息，浙商基金近期对2家上市公司进行了调研，相关名单如下：1)晨光生物 . 浙商基金成立于2010年，截至目前，资产管理规模292.67亿元，排名105/212；资产管理规模213.59亿元，排名103/212；管理公募基金数74只，排名83/212；旗下公募基金经理14人，排名93/212。旗下最近一年表现最佳的公募基金产品为浙商智选经济动能混合A，最新单位净值为0.93，近一年增长55.06%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260428/32182586.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["300138","BK0042","BK0077","300181","BK0239","BK0238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630235642","title":"晨光生物：4月25日接受机构调研，国泰海通、鹏扬基金等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2630235642","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630235642?lang=zh_cn&edition=full","pubTime":"2026-04-27 11:30","pubTimestamp":1777260627,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年4月27日晨光生物发布公告称公司于2026年4月25日接受机构调研，国泰海通林逸丹、鹏扬基金曹敏、浙商基金刘耘娜、方正证券卢潇航、前海开源基金毕建强、中信证券江皓云、林毓鑫、海富通基金叶俊仙、瑞银刘思莹、财通证券马咏怡、泓德基金季宇、华安基金刘潇、招商基金王宁远、天风证券徐盛参与。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700017319.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300138","BK0276","BK0028","BK0184","601211","BK1564","BK0012","BK0183","BK0201","BK0188","BK0238","BK1147","02611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630342233","title":"股市必读：晨光生物一季报 - 第一季度单季净利润同比下降11.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630342233","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630342233?lang=zh_cn&edition=full","pubTime":"2026-04-27 07:24","pubTimestamp":1777245854,"startTime":"0","endTime":"0","summary":"股本股东变化股东户数变动近日晨光生物披露，截至2026年4月20日公司股东户数为1.89万户，较3月31日减少561.0户，减幅为2.88%。业绩披露要点财务报告晨光生物2026年一季报显示，一季度公司主营收入16.29亿元，同比下降5.1%；归母净利润9672.16万元，同比下降11.65%；扣非净利润9552.76万元，同比下降0.41%；负债率68.23%，投资收益453.4万元，财务费用2697.77万元，毛利率13.68%。2026年第一季度报告已同步披露于巨潮资讯网。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700007116.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300138"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630870623","title":"晨光生物(300138)4月20日股东户数1.89万户，较上期减少2.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630870623","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630870623?lang=zh_cn&edition=full","pubTime":"2026-04-25 17:11","pubTimestamp":1777108310,"startTime":"0","endTime":"0","summary":"证券之星消息，近日晨光生物披露，截至2026年4月20日公司股东户数为1.89万户，较3月31日减少561.0户，减幅为2.88%。在农产品加工行业个股中，晨光生物股东户数低于行业平均水平，截至4月20日，农产品加工行业平均股东户数为3.43万户。从股价来看，2026年3月31日至2026年4月20日，晨光生物区间跌幅为0.5%，在此期间股东户数减少561.0户，减幅为2.88%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042500032623.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300138","BK0238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629204846","title":"晨光生物(300138.SZ)发布一季度业绩，归母净利润9672.16万元，下降11.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629204846","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629204846?lang=zh_cn&edition=full","pubTime":"2026-04-24 20:01","pubTimestamp":1777032096,"startTime":"0","endTime":"0","summary":"智通财经APP讯，晨光生物(300138.SZ)发布2026年第一季度报告，该公司营业收入为16.29亿元，同比减少5.10%。归属于上市公司股东的净利润为9672.16万元，同比减少11.65%。归属于上市公司股东的扣除非经常性损益的净利润为9552.76万元，同比减少0.41%。基本每股收益为0.2002元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433647.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300138"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629881166","title":"4月23日晨光生物现1笔折价15.67%的大宗交易 合计成交396万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2629881166","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629881166?lang=zh_cn&edition=full","pubTime":"2026-04-23 17:21","pubTimestamp":1776936062,"startTime":"0","endTime":"0","summary":"证券之星消息，4月23日晨光生物发生大宗交易，交易数据如下：大宗交易成交价格9.9元，相对当日收盘价折价15.67%，成交40万股，成交金额396万元，买方营业部为渤海证券股份有限公司北京大兴兴华大街证券营业部，卖方营业部为中信证券股份有限公司石家庄槐安东路证券营业部。近三个月该股共发生2笔大宗交易，合计成交8460.0手，折价成交2笔。截至2026年4月23日收盘，晨光生物报收于11.74元，下跌2.09%，换手率1.72%，成交量6.87万手，成交额8120.33万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300047319.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300138","BK0238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627023419","title":"股市必读：晨光生物（300138）4月15日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2627023419","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627023419?lang=zh_cn&edition=full","pubTime":"2026-04-16 02:10","pubTimestamp":1776276622,"startTime":"0","endTime":"0","summary":"截至2026年4月15日收盘，晨光生物报收于12.03元，下跌0.5%，换手率1.23%，成交量4.92万手，成交额5926.75万元。董秘最新回复投资者： 贵公司在市值管理方面做了哪些计划？","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600002466.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","300138"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627651472","title":"晨光生物：2026年棉籽业务将继续严格执行对锁经营模式","url":"https://stock-news.laohu8.com/highlight/detail?id=2627651472","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627651472?lang=zh_cn&edition=full","pubTime":"2026-04-15 11:34","pubTimestamp":1776224067,"startTime":"0","endTime":"0","summary":"证券之星消息，晨光生物(300138)04月15日在投资者关系平台上答复投资者关心的问题。投资者提问：棉籽业务2025年扭亏，2026年盈利稳定性与风险敞口管控？晨光生物回复：您好，2026年棉籽业务将继续严格执行对锁经营模式，强化敞口管理，规避价格波动风险。同时继续开展期货套期保值业务，规避原材料及生产过程产品市场价格剧烈波动对公司经营带来的影响，提高公司抗风险能力，保障棉籽类业务经营稳定。谢谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500018875.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","300138"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627472675","title":"晨光生物：美国FDA推动食品行业从合成色素向天然色素转型","url":"https://stock-news.laohu8.com/highlight/detail?id=2627472675","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627472675?lang=zh_cn&edition=full","pubTime":"2026-04-15 11:34","pubTimestamp":1776224065,"startTime":"0","endTime":"0","summary":"证券之星消息，晨光生物(300138)04月15日在投资者关系平台上答复投资者关心的问题。投资者提问：美国FDA替代合成色素红利，2026年出口与订单兑现情况？晨光生物回复：您好，美国FDA正在推动食品行业从合成色素向天然色素转型，对天然色素销量提升、客户粘性增强、产品附加值提高有重要作用。公司持续推动天然色素替代合成色素使用，2026年度经营情况请关注公司届时在符合条件媒体披露的定期报告。谢谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500018870.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","300138"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627472697","title":"晨光生物：公司管理层始终重视公司价值的提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2627472697","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627472697?lang=zh_cn&edition=full","pubTime":"2026-04-15 11:34","pubTimestamp":1776224064,"startTime":"0","endTime":"0","summary":"证券之星消息，晨光生物(300138)04月15日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司在市值管理方面做了哪些计划？晨光生物回复：您好，公司管理层始终重视公司价值的提升，致力于通过稳健经营、规范运作，不断提高公司质量，提升公司回报股东能力。在此基础上公司持续做好投资者关系管理，增强信息披露质量和透明度，必要时积极采取措施提振投资者信心，谢谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500018864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300138","BK0238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626171877","title":"西南证券：给予晨光生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2626171877","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626171877?lang=zh_cn&edition=full","pubTime":"2026-04-12 14:45","pubTimestamp":1775976315,"startTime":"0","endTime":"0","summary":"西南证券股份有限公司朱会振,舒尚立近期对晨光生物进行研究并发布了研究报告《2025年报点评：棉籽大幅扭亏，上行拐点将至》，给予晨光生物买入评级。 盈利预测与投资建议：预计2026-2028年归母净利润分别为4.5、5.5、6.3亿元，EPS分别为0.93元、1.14元、1.31元，维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有7家机构给出评级，买入评级5家，增持评级2家；过去90天内机构目标均价为15.66。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041200002739.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300138","600369"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626977609","title":"晨光生物：2025年实现归属于上市公司股东的净利润3.69亿元，同比增长292.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2626977609","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626977609?lang=zh_cn&edition=full","pubTime":"2026-04-09 11:33","pubTimestamp":1775705637,"startTime":"0","endTime":"0","summary":"证券之星消息，晨光生物04月09日在投资者关系平台上答复投资者关心的问题。投资者提问：2025年，公司高管薪酬总额增长率为54.69%，而营业收入增长率只有-6.22%，差额较大且远超同行，请问这合理吗？晨光生物回复：您好，2025年公司全年实现收入65.59亿元，同比下降6.22%；实现归属于上市公司股东的净利润3.69亿元，同比增长292.21%；扣除非经常性损益后的归属于上市公司股东的净利润及基本每股收益分别同比增长530.28%和 320.02%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040900015346.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300138"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625682939","title":"晨光生物（300138）披露向参股公司增资进展公告，4月7日股价上涨0.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625682939","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625682939?lang=zh_cn&edition=full","pubTime":"2026-04-07 17:33","pubTimestamp":1775554397,"startTime":"0","endTime":"0","summary":"截至2026年4月7日收盘，晨光生物报收于11.87元，较前一交易日上涨0.51%，最新总市值为57.34亿元。该股当日开盘11.9元，最高12.08元，最低11.75元，成交额达1.08亿元，换手率为2.28%。近日，晨光生物科技集团股份有限公司披露《关于向参股公司增资的进展公告》。公告显示，公司于2026年3月31日召开第五届董事会第二十二次会议，审议通过向参股公司河北晨华农业科技有限公司按持股比例增资2,000万元，另一股东河北华裕永诚食品有限公司亦同比例增资。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700024488.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300138","BK0238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624659978","title":"中邮证券：给予晨光生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2624659978","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624659978?lang=zh_cn&edition=full","pubTime":"2026-04-03 17:35","pubTimestamp":1775208930,"startTime":"0","endTime":"0","summary":"中邮证券有限责任公司王琦近期对晨光生物进行研究并发布了研究报告《棉籽大幅扭亏，植提韧性显现》，给予晨光生物买入评级。我们看好公司成长性，维持“买入”评级。 风险提示：原材料价格波动风险，销量不及预期风险最新盈利预测明细如下：该股最近90天内共有6家机构给出评级，买入评级4家，增持评级2家；过去90天内机构目标均价为15.66。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300034521.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","300138"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624595181","title":"晨光生物：公司目前生产经营正常，产品出口业务有序开展","url":"https://stock-news.laohu8.com/highlight/detail?id=2624595181","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624595181?lang=zh_cn&edition=full","pubTime":"2026-04-01 16:30","pubTimestamp":1775032224,"startTime":"0","endTime":"0","summary":"证券之星消息，晨光生物(300138)04月01日在投资者关系平台上答复投资者关心的问题。投资者提问：贵司被美国制裁，产品还能进入美国市场吗？制裁在申诉处理吗？会有什么变化？晨光生物回复：您好，公司目前生产经营正常，产品出口业务有序开展。公司将持续关注外部环境变化，积极开拓多元化国际市场。谢谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040100029623.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300138","BK0238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623311036","title":"晨光生物最新公告：2026年第一季度净利同比变动-17.79%-5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623311036","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623311036?lang=zh_cn&edition=full","pubTime":"2026-03-30 19:09","pubTimestamp":1774868982,"startTime":"0","endTime":"0","summary":"晨光生物(300138.SZ)公告称，公司预计2026年第一季度归属于上市公司股东的净利润为9,000万元至11,500万元，同比增长-17.79%至5.04%。业绩变动原因：公司业务稳健，充分利用存货调整销售策略；赞比亚子公司受自然灾害影响成本上升、毛利率下降延续，致业绩基本持平略有波动。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000029260.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","300138"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622784250","title":"晨光生物（300138）披露为参股公司银行借款提供担保的进展公告，3月27日股价上涨1.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622784250","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622784250?lang=zh_cn&edition=full","pubTime":"2026-03-27 17:26","pubTimestamp":1774603580,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，晨光生物报收于13.09元，较前一交易日上涨1.63%，最新总市值为63.24亿元。公司于近日披露《关于为参股公司银行借款提供担保的进展公告》。公告显示，晨光生物科技集团股份有限公司于2025年4月3日召开董事会、2025年5月6日召开股东大会，审议通过为参股公司新疆晨丰源油脂有限公司银行借款提供担保的议案。截至目前，公司对合并报表外参股公司已签订担保协议余额为1,158.25万元，占公司最近一期经审计净资产的0.37%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700036481.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300138","BK0238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620275330","title":"股市必读：晨光生物（300138）3月19日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2620275330","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620275330?lang=zh_cn&edition=full","pubTime":"2026-03-20 03:04","pubTimestamp":1773947054,"startTime":"0","endTime":"0","summary":"截至2026年3月19日收盘，晨光生物报收于13.43元，下跌4.0%，换手率2.28%，成交量9.09万手，成交额1.23亿元。董秘最新回复投资者： 请问公司最近一期的股东数量多少？","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032000002530.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","300138"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620145252","title":"晨光生物：莱鲍迪甙M高效生物合成项目入选河北省生物合成专项","url":"https://stock-news.laohu8.com/highlight/detail?id=2620145252","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620145252?lang=zh_cn&edition=full","pubTime":"2026-03-19 15:03","pubTimestamp":1773903792,"startTime":"0","endTime":"0","summary":"证券之星消息，晨光生物(300138)03月19日在投资者关系平台上答复投资者关心的问题。投资者提问：公司目前在合成生物方面的布局有什么进展吗？晨光生物回复：您好，公司高度关注合成生物技术的发展动向，已针对相关产品进行研发，其中莱鲍迪甙M高效生物合成项目入选河北省生物合成专项。目前天然植物提取技术更符合消费者天然健康的消费理念，生产技术成熟稳定，产品成本具备市场优势。谢谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031900018478.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300138","BK0238"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1777577115521,"stockEarnings":[{"period":"1week","weight":-0.0179},{"period":"1month","weight":-0.0471},{"period":"3month","weight":-0.1491},{"period":"6month","weight":-0.137},{"period":"1year","weight":0.0812},{"period":"ytd","weight":-0.0709}],"compareEarnings":[{"period":"1week","weight":0.0046},{"period":"1month","weight":0.0566},{"period":"3month","weight":-0.0014},{"period":"6month","weight":0.0398},{"period":"1year","weight":0.2541},{"period":"ytd","weight":0.0361}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"晨光生物科技集团股份有限公司","boardCode":"AI0013","boardName":"农副食品加工业","stockholders":"18895人(较上一季度减少2.88%)","perCapita":"21080股","listingDate":"2010-11-05","address":"河北省邯郸市曲周县城晨光路1号","registeredCapital":"48310万元","survey":" 晨光生物科技集团股份有限公司的主营业务是天然植物提取。公司的主要产品是天然色素、天然香辛料提取物和精油、天然营养及药用提取物、天然甜味剂、保健食品、油脂和蛋白。公司先后荣获农业产业化国家重点龙头企业、国家高新技术企业、国家技术创新示范企业。","listedPrice":30},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"晨光生物(300138)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供晨光生物(300138)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"晨光生物,300138,晨光生物股票,晨光生物股票老虎,晨光生物股票老虎国际,晨光生物行情,晨光生物股票行情,晨光生物股价,晨光生物股市,晨光生物股票价格,晨光生物股票交易,晨光生物股票购买,晨光生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"晨光生物(300138)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供晨光生物(300138)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}